Table of Contents
PISCATAWAY, N.J.– Camber Pharmaceuticals is pleased to announce the addition of zileuton ER tablets to its current portfolio.
Zileuton ER tablets are indicated for the prophylaxis and chronic treatment of asthma in adults and children 12 years of age and older. Zileuton ER tablets are not indicated for use in the reversal of bronchospasm in acute asthma attacks. Therapy with zileuton ER tablets can be continued during acute exacerbations of asthma.
Zileuton ER tablets are available in 600 mg strength in 120 count bottles. For more info, visit www.camberpharma.com
